|
|
|
|
| LEADER |
02506nam a2200409 a 4500 |
| 001 |
000000057856 |
| 003 |
OSt |
| 005 |
20230811114202.0 |
| 008 |
150601b ho xxu||||| |||| 00| 0 spa d |
| 040 |
|
|
|a Sistema de Bibliotecas UNAH
|
| 044 |
|
|
|a HN
|
| 082 |
0 |
|
|a 317.283- V182p
|
| 100 |
1 |
|
|a Vallejo, Antonio R
|9 32627
|
| 245 |
1 |
0 |
|a Primer anuario estadístico correspondinte al año 1893
|c Antonio R. Vallejo
|
| 260 |
|
|
|a Tegucigalpa, Honduras
|b Tipografia Nacional
|c 1893
|
| 300 |
|
|
|a VII., 262 p.
|b il., cuadros
|c 37 cm.
|
| 500 |
|
|
|a [v.1, v2,v3 y v4]
|
| 650 |
|
4 |
|a DATOS ESTADISTICOS
|9 20817
|
| 650 |
|
4 |
|a DELITOS
|9 5226
|
| 650 |
|
4 |
|a DELINCUENTES
|
| 901 |
|
|
|a BINAHON
|
| 903 |
|
|
|a 19940609 DM VG MS
|
| 942 |
|
|
|2 ddc
|c FDA
|
| 999 |
|
|
|c 57856
|d 57856
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.2
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161634
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436184
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 v.2
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161635
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436185
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.1
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161636
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436186
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.3
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161637
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436187
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.3, C.2
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161638
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436188
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.4, C.2
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 161639
|a CLRA
|b BH
|l 0
|o 317.283-V182p
|p 436189
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 349031
|a CLRA
|b BHCUROC
|d 2018-05-23
|l 0
|o 317.283-V182p
|p 543937
|r 2018-05-23
|w 2018-05-23
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 349032
|a CLRA
|b BHCUROC
|d 2018-05-23
|l 0
|o 317.283-V182p
|p 543938
|r 2018-05-23
|w 2018-05-23
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 349033
|a CLRA
|b BHCUROC
|d 2018-05-23
|l 0
|o 317.283-V182p
|p 543939
|r 2018-05-23
|w 2018-05-23
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 349034
|a CLRA
|b BHCUROC
|d 2018-05-23
|l 0
|o 317.283-V182p
|p 543940
|r 2018-05-23
|w 2018-05-23
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 349035
|a CLRA
|b BHCUROC
|d 2018-05-23
|l 0
|o 317.283-V182p
|p 543941
|r 2018-05-23
|w 2018-05-23
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|3 V.1
|4 0
|6 317_000000000000000_283V182P
|7 0
|9 382015
|a CLRA
|b BH
|d 2023-03-02
|o 317.283-V182p
|p 629427
|r 2023-03-02
|w 2023-03-02
|y FDA
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 317_000000000000000_283_V182P
|7 0
|9 383084
|a CLRA
|b BH
|d 2023-07-11
|o 317.283- V182p
|p 630517
|r 2023-07-11
|w 2023-07-11
|y FDA
|